Marina Biotech, Inc.  

(Public, OTCMKTS:MRNA)   Watch this stock  
Find more results for NASDAQ:NSTK
-0.013 (-4.56%)
Nov 27 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.27 - 0.27
52 week 0.21 - 1.10
Open 0.27
Vol / Avg. 5,948.00/38,872.00
Mkt cap 7.37M
P/E 0.52
Div/yield     -
EPS 0.52
Shares 27.08M
Beta -0.08
Inst. own 0%
Feb 23, 2016
Q4 2015 Marina Biotech Inc Earnings Release (Estimated) Add to calendar
Nov 16, 2015
Q3 2015 Marina Biotech Inc Earnings Release

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 1823.75% -1295.40%
Operating margin -1282.50% -596.20%
EBITD margin - -704.00%
Return on average assets 74.66% -76.39%
Return on average equity - -
Employees 1 -
CDP Score - -


3830 Monte Villa Pkwy
BOTHELL, WA 98021-7266
United States - Map
+1-425-9083600 (Phone)
+1-302-6745266 (Fax)

Website links


Marina Biotech, Inc. is a biotechnology company focused on the discovery, development and commercialization of nucleic acid-based therapies to treat orphan diseases. The Company's pipeline is orphan disease focused and includes a clinical program in Familial Adenomatous Polyposis (FAP) and preclinical programs in type 1 myotonic dystrophy (DM1) and Duchenne's muscular dystrophy (DMD). Its partners, ProNAi Therapeutics, Inc. (ProNAi) and Mirna Therapeutics, Inc. (Mirna) are focused on oncology and have clinical programs in recurrent or refractory non-Hodgkin's lymphoma and unresectable primary liver cancer or solid cancers with liver involvement, respectively. The Company has two liposomal-based delivery platforms. The first platform, SMARTICLES, defines a class of liposomes that are charge-reversible particles allowing delivery of active substance. The second platform utilizes amino-based liposomal delivery technology.

Officers and directors

J. Michael French Chairman of the Board, President, Chief Executive Officer
Age: 55
Daniel E. Geffken CPA Interim Chief Financial Officer
Age: 58
Stefan D. Loren Ph.D. Lead Independent Director
Age: 50
Philip C. Ranker Director
Age: 54
Trading Activity - Yahoo Finance
Joseph W. Ramelli Independent Director
Age: 46
Donald A. Williams Independent Director
Age: 56